Skip to main content
Top
Published in: Journal of Anesthesia 2/2010

01-04-2010 | Short Communication

Lidocaine pretreatment reduces the frequency and severity of myoclonus induced by etomidate

Authors: Fethi Gultop, Taylan Akkaya, Nurdan Bedirli, Haluk Gumus

Published in: Journal of Anesthesia | Issue 2/2010

Login to get access

Abstract

The objective of this study was to assess the effects of lidocaine on the incidence and severity of myoclonic movements induced by etomidate. Sixty patients were randomly assigned to receive either 20 mg lidocaine or saline (n = 30, each), 30 s before administration of etomidate (0.3 mg/kg). One minute after etomidate administration we assessed severity of myoclonus. Pretreatment with lidocaine significantly reduced both the incidence and severity of myoclonic movements. As a conclusion, lidocaine is an effective and safe drug to reduce the etomidate-induced myoclonus without significant side effects.
Literature
1.
go back to reference Ruth WJ, Burton JH, Bock AJ. Intravenous etomidate for procedural sedation in emergency department patients. Acad Emerg Med. 2001;8:13–8.CrossRefPubMed Ruth WJ, Burton JH, Bock AJ. Intravenous etomidate for procedural sedation in emergency department patients. Acad Emerg Med. 2001;8:13–8.CrossRefPubMed
2.
go back to reference Doenicke AW, Roizen MF, Hoernecke R, Lorenz W, Ostwald P. Solvent for etomidate may cause pain and adverse effects. Br J Anaesth. 1999;83:464–6.PubMed Doenicke AW, Roizen MF, Hoernecke R, Lorenz W, Ostwald P. Solvent for etomidate may cause pain and adverse effects. Br J Anaesth. 1999;83:464–6.PubMed
3.
go back to reference Nyman Y, Von Hofsten K, Palm C, Eksborg S, Lönnquist PA. Etomidate-Lipuro is associated with considerable less injection pain in children compared with propofol with added lidocaine. Br J Anaesth. 2006;97:536–9.CrossRefPubMed Nyman Y, Von Hofsten K, Palm C, Eksborg S, Lönnquist PA. Etomidate-Lipuro is associated with considerable less injection pain in children compared with propofol with added lidocaine. Br J Anaesth. 2006;97:536–9.CrossRefPubMed
4.
go back to reference Doenicke A, Roizen MF, Nebauer AE, Kugler A, Beger-Hintzen H. A comparison of two formulations for etomidate, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and propylene glycol. Anesth Analg. 1994;79:933–9.CrossRefPubMed Doenicke A, Roizen MF, Nebauer AE, Kugler A, Beger-Hintzen H. A comparison of two formulations for etomidate, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and propylene glycol. Anesth Analg. 1994;79:933–9.CrossRefPubMed
5.
go back to reference Kulka PJ, Bremer F, Schüttler J. Anesthesia induction using etomidate in a lipid emulsion. Anaesthetist. 1993;42:205–9. Kulka PJ, Bremer F, Schüttler J. Anesthesia induction using etomidate in a lipid emulsion. Anaesthetist. 1993;42:205–9.
6.
go back to reference Schwarzkopf KR, Hueter L, Simon M, Fritz HB. Midazolam pretreatment reduces etomidate-induced myoclonic movements. Anaesth Intensive Care. 2003;31:18–20.PubMed Schwarzkopf KR, Hueter L, Simon M, Fritz HB. Midazolam pretreatment reduces etomidate-induced myoclonic movements. Anaesth Intensive Care. 2003;31:18–20.PubMed
7.
go back to reference Stockham RJ, Stanley TH, Pace NL, Gillmor S, Groen F, Hilkens P. Fentanyl pretreatment modifies anaesthetic induction with etomidate. Anaesth Intensive Care. 1988;16:171–6.PubMed Stockham RJ, Stanley TH, Pace NL, Gillmor S, Groen F, Hilkens P. Fentanyl pretreatment modifies anaesthetic induction with etomidate. Anaesth Intensive Care. 1988;16:171–6.PubMed
8.
go back to reference Hueter L, Schwarzkopf K, Simon M, Bredle D, Fritz H. Pretreatment with sufentanil reduces myoclonus after etomidate. Acta Anaesthesiol Scand. 2003;47:482–4.CrossRefPubMed Hueter L, Schwarzkopf K, Simon M, Bredle D, Fritz H. Pretreatment with sufentanil reduces myoclonus after etomidate. Acta Anaesthesiol Scand. 2003;47:482–4.CrossRefPubMed
9.
go back to reference Kelsaka E, Karakaya D, Sarihasan B, Baris S. Remifentanil pretreatment reduces myoclonus after etomidate. J Clin Anesth. 2006;18:83–6.CrossRefPubMed Kelsaka E, Karakaya D, Sarihasan B, Baris S. Remifentanil pretreatment reduces myoclonus after etomidate. J Clin Anesth. 2006;18:83–6.CrossRefPubMed
10.
go back to reference Hüter L, Schereiber T, Guegel M, Schwerzkopf K. Low-dose intravenous midazolam reduces etomidate-induced myoclonus: A prospective, randomized study in patients undergoing elective cardioversion. Anesth Analg. 2007;105:1298–302.CrossRefPubMed Hüter L, Schereiber T, Guegel M, Schwerzkopf K. Low-dose intravenous midazolam reduces etomidate-induced myoclonus: A prospective, randomized study in patients undergoing elective cardioversion. Anesth Analg. 2007;105:1298–302.CrossRefPubMed
11.
go back to reference Wagler L, White PF, Kan PB, Rosenthal MH, Feldman D. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med. 1984;310:1415–21.CrossRef Wagler L, White PF, Kan PB, Rosenthal MH, Feldman D. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med. 1984;310:1415–21.CrossRef
12.
go back to reference Doenicke AW, Roizen MF, Kugler J, Kroll H, Foss J, Ostwald P. Reducing myoclonus after etomidate. Anesthesiology. 1999;90:113–9.CrossRefPubMed Doenicke AW, Roizen MF, Kugler J, Kroll H, Foss J, Ostwald P. Reducing myoclonus after etomidate. Anesthesiology. 1999;90:113–9.CrossRefPubMed
13.
go back to reference Hwang J-Y, Kim J-H, Oh A-Y, Do SH, Jeon YT, Han SH. A comparison of midazolam with remifentanil for prevention of myoclonic movements following etomidate injection. J Int Med Res. 2008;36:17–22.PubMed Hwang J-Y, Kim J-H, Oh A-Y, Do SH, Jeon YT, Han SH. A comparison of midazolam with remifentanil for prevention of myoclonic movements following etomidate injection. J Int Med Res. 2008;36:17–22.PubMed
14.
go back to reference Reddy RV, Moorthy SS, Dierdorf SF, Deitch RD Jr, Link L. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital and propofol. Anesth Analg. 1993;77:1008–11.CrossRefPubMed Reddy RV, Moorthy SS, Dierdorf SF, Deitch RD Jr, Link L. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital and propofol. Anesth Analg. 1993;77:1008–11.CrossRefPubMed
15.
go back to reference Modica PA, Tempelhoff R, White PF. Pro- and anticonvulsant effects of anesthetics (Part II). Anesth Analg. 1990;70:433–44.PubMed Modica PA, Tempelhoff R, White PF. Pro- and anticonvulsant effects of anesthetics (Part II). Anesth Analg. 1990;70:433–44.PubMed
16.
go back to reference Choi JM, Choi IC, Jeong YB, Kim TH, Hahm KD. Pretreatment of rocuronium reduces the frequency and severity of etomidate-induced myoclonus. J Clin Anesth. 2009;20:601–4.CrossRef Choi JM, Choi IC, Jeong YB, Kim TH, Hahm KD. Pretreatment of rocuronium reduces the frequency and severity of etomidate-induced myoclonus. J Clin Anesth. 2009;20:601–4.CrossRef
17.
go back to reference Scott RP, Saunders DA, Norman J. Propofol: clinical strategies for preventing pain of injection. Anaesthesia. 1988;43:492–4.CrossRefPubMed Scott RP, Saunders DA, Norman J. Propofol: clinical strategies for preventing pain of injection. Anaesthesia. 1988;43:492–4.CrossRefPubMed
Metadata
Title
Lidocaine pretreatment reduces the frequency and severity of myoclonus induced by etomidate
Authors
Fethi Gultop
Taylan Akkaya
Nurdan Bedirli
Haluk Gumus
Publication date
01-04-2010
Publisher
Springer Japan
Published in
Journal of Anesthesia / Issue 2/2010
Print ISSN: 0913-8668
Electronic ISSN: 1438-8359
DOI
https://doi.org/10.1007/s00540-010-0869-6

Other articles of this Issue 2/2010

Journal of Anesthesia 2/2010 Go to the issue